Jarislowsky, Fraser Ltd’s AstraZeneca AZN Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.5M	Buy	9,774 +1,143	+13%	+$173K	0.01%	135
2025 Q2	$1.21M	Buy	8,631 +1,290	+18%	+$181K	0.01%	138
2025 Q1	$1.08M	Sell	7,341 -683	-9%	-$98.8K	0.01%	140
2024 Q4	$1.05M	Buy	8,024 +1,828	+30%	+$256K	0.01%	140
2024 Q3	$965K	Sell	6,196 -864	-12%	-$139K	0.01%	140
2024 Q2	$1.1M	Buy	7,060 +18	+0.3%	+$2.71K	0.01%	139
2024 Q1	$954K	Buy	7,042 +1,160	+20%	+$154K	0.01%	148
2023 Q4	$792K	Sell	5,882 -37	-0.6%	-$4.81K	﹤0.01%	165
2023 Q3	$802K	Buy	5,919 +1,513	+34%	+$207K	0.01%	149
2023 Q2	$631K	Buy	+4,406	New	+$648K	﹤0.01%	154

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jarislowsky, Fraser Ltd's AZN Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd increased its AstraZeneca (AZN) stake by 13% in Q3 2025, buying an estimated $173K and bringing the position to 9,774 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #135.

Jarislowsky, Fraser Ltd first reported a position in AZN in Q2 2023 and has held it in 10 quarters since. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Jarislowsky, Fraser Ltd held 9,774 shares of AstraZeneca worth $1.5M as of Q3 2025.
Jarislowsky, Fraser Ltd bought 1,143 AstraZeneca shares in Q3 2025, an estimated $173K.
AstraZeneca made up 0.01% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #135 holding.
Jarislowsky, Fraser Ltd first reported a position in AstraZeneca in Q2 2023 and has held it in 10 quarters since.
1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.